Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.
Antibody biotech Diagonal Therapeutics lands $128M to pursue rare diseases
Diagonal Therapeutics has launched with $128 million to go after an orphan disease that leads to chronic anemia, and another antibody for the same rare